S 1637
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Sponsors2 cosponsors more
Markwayne MullinCongressS 1637
MVP Act
Congress · In committee
Lobbied on it8 of 10
Alliance for Regenerative Medicine11 reportsAmerica'S Health Insurance Plans Inc (Ahip)8 reportsBiomarin Pharmaceutical Inc.6 reportsPharmaceutical Research and Manufacturers of America6 reportsGSK (Fka Glaxosmithkline Inc.)4 reportsAvenue Solutions3 reportsPharmaceutical Care Management Association2 reportsSpark Therapeutics, Inc.2 reportsEvery link on this map
The same connections as a table, with the reason each one is here.
| Markwayne Mullin | Sponsors | Markwayne Mullin sponsored S 1637. | None |
| Alliance for Regenerative Medicine | Lobbied on it | Alliance for Regenerative Medicine named S 1637 in 11 lobbying reports. | 11 reports |
| America'S Health Insurance Plans Inc (Ahip) | Lobbied on it | America'S Health Insurance Plans Inc (Ahip) named S 1637 in 8 lobbying reports. | 8 reports |
| Biomarin Pharmaceutical Inc. | Lobbied on it | Biomarin Pharmaceutical Inc. named S 1637 in 6 lobbying reports. | 6 reports |
| Pharmaceutical Research and Manufacturers of America | Lobbied on it | Pharmaceutical Research and Manufacturers of America named S 1637 in 6 lobbying reports. | 6 reports |
| GSK (Fka Glaxosmithkline Inc.) | Lobbied on it | GSK (Fka Glaxosmithkline Inc.) named S 1637 in 4 lobbying reports. | 4 reports |
| Avenue Solutions | Lobbied on it | Avenue Solutions named S 1637 in 3 lobbying reports. | 3 reports |
| Pharmaceutical Care Management Association | Lobbied on it | Pharmaceutical Care Management Association named S 1637 in 2 lobbying reports. | 2 reports |
| Spark Therapeutics, Inc. | Lobbied on it | Spark Therapeutics, Inc. named S 1637 in 2 lobbying reports. | 2 reports |